SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-320117
Filing Date
2018-11-07
Accepted
2018-11-07 07:17:05
Documents
2
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d651688d8k.htm 8-K 17256
2 EX-99.1 d651688dex991.htm EX-99.1 65279
  Complete submission text file 0001193125-18-320117.txt   83764
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 181164695
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences